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Abstract
© Copyright 2017 Anna Makeeva et al. Extracellular bacterial ribonucleases such as binase from
Bacillus  pumilus  possess  cytotoxic  activity  against  tumor  cells  with  a  potential  for  clinical
application. Moreover, they may induce activation of tumor-derived macrophages either into the
M1-phenotype  with  well-documented  functions  in  the  regulation  of  the  antitumor  immune
response  or  into  M2-macrophages  that  may  stimulate  tumor  growth,  metastasis,  and
angiogenesis.  In  this  study,  binase  or  endogenous  RNase1  (but  not  RNA  or  short
oligonucleotides) stimulated the expression of activated NF-κB p65 subunit in macrophages.
Since  no  changes  in  MyD88 and  TRIF  adaptor  protein  expression  were  observed,  toll-like
receptors may not be involved in RNase-related NF-κB pathway activation. In addition, short
exposure (0.5 hr) to binase induced the release of cytokines such as IL-6, MCP-1, or TNF-α (but
not IL-4 and IL-10), indicative for the polarization into antitumor M1-macrophages. Thus, we
revealed increased expression of activated NF-κB p65 subunit in macrophages upon stimulation
by binase and RNase1, but not RNA or short oligonucleotides.
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